venBio Global Strategic GP II, L.P. insider trades: Checkmate Pharmaceuticals (CMPI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where venBio Global Strategic GP II, L.P. reports to the SEC
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 16, 2022 | CMPI | ↓ Sell | 131,650 | $10.45 | $1.4M | Direct | May 17, 2022 (1d) |
| May 12, 2022 | CMPI | ↓ Sell | 160,901 | $10.39 | $1.7M | Direct | May 12, 2022 (0d) |
| May 9, 2022 | CMPI | ↓ Sell | 86,677 | $10.37 | $899K | Direct | May 9, 2022 (0d) |
| May 4, 2022 | CMPI | ↓ Sell | 270,675 | $10.38 | $2.8M | Direct | May 4, 2022 (0d) |
| Apr 29, 2022 | CMPI | ↓ Sell | 190,026 | $10.38 | $2.0M | Direct | Apr 29, 2022 (0d) |
| Apr 26, 2022 | CMPI | ↓ Sell | 129,781 | $10.39 | $1.3M | Direct | Apr 26, 2022 (0d) |
| Apr 21, 2022 | CMPI | ↓ Sell | 547,734 | $10.41 | $5.7M | Direct | Apr 21, 2022 (0d) |
| Apr 27, 2021 | IMPL | ↑ Buy | 450,000 | $15.00 | $6.8M | Direct | Apr 29, 2021 (2d) |
| Aug 11, 2020 | CMPI | ↑ Buy | 200,000 | $15.00 | $3.0M | Direct | Aug 12, 2020 (1d) |
| Jul 21, 2020 | ALXO | ↑ Buy | 850,000 | $19.00 | $16.1M | Indirect | Jul 21, 2020 (0d) |
| Jul 21, 2020 | ALXO | ↑ Buy | 3,000 | $19.00 | $57K | Direct | Jul 21, 2020 (0d) |
| Jul 6, 2020 | AKRO | ↓ Sell | 116,467 | $34.40 | $4.0M | Indirect | Jul 6, 2020 (0d) |
| Mar 6, 2020 | AKRO | ↓ Sell | 45,950 | $23.76 | $1.1M | Indirect | Mar 6, 2020 (0d) |
| Mar 3, 2020 | AKRO | ↓ Sell | 21,798 | $22.63 | $493K | Indirect | Mar 3, 2020 (0d) |
| Feb 27, 2020 | AKRO | ↓ Sell | 5,904 | $22.80 | $135K | Indirect | Feb 27, 2020 (0d) |
| Feb 12, 2020 | AKRO | ↓ Sell | 10,026 | $27.07 | $271K | Indirect | Feb 12, 2020 (0d) |
| Feb 6, 2020 | AKRO | ↓ Sell | 6,102 | $27.03 | $165K | Indirect | Feb 10, 2020 (4d) |
| Feb 5, 2020 | AKRO | ↓ Sell | 82,339 | $25.77 | $2.1M | Indirect | Feb 6, 2020 (1d) |
| Jan 13, 2020 | AKRO | ↓ Sell | 494,000 | $20.23 | $10.0M | Indirect | Jan 14, 2020 (1d) |
| Jan 8, 2020 | AKRO | ↓ Sell | 15,677 | $19.86 | $311K | Indirect | Jan 10, 2020 (2d) |
| Jan 7, 2020 | AKRO | ↓ Sell | 73,221 | $19.86 | $1.5M | Indirect | Jan 8, 2020 (1d) |
| Jan 3, 2020 | AKRO | ↓ Sell | 35,498 | $19.71 | $700K | Indirect | Jan 6, 2020 (3d) |
| Dec 31, 2019 | AKRO | ↓ Sell | 14,324 | $23.96 | $343K | Indirect | Jan 3, 2020 (3d) |
| Jun 24, 2019 | AKRO | ↑ Buy | 250,000 | $16.00 | $4.0M | Indirect | Jun 25, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About venBio Global Strategic GP II, L.P.'s insider trades
venBio Global Strategic GP II, L.P. is a 10% owner of Checkmate Pharmaceuticals (CMPI). Since Jun 24, 2019, it has reported 5 open-market purchases worth $30.0M and 19 sales worth $36.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CMPI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.